SCHEDULE: Value Base Group Boosts SHL Telemedicine Stake to 15.18%

Value Base Ltd. and its affiliates increased their beneficial ownership in SHL Telemedicine Ltd. to 15.18% following a $3.2 million investment in a recent rights offering.

Summary

• Value Base Ltd., Value Base Hedge Fund Ltd. (as general partner to Harmony Base, Limited Partnership), Ido Nouberger, and Victor Shamrich (collectively, the "Reporting Persons") have increased their aggregate beneficial ownership in SHL Telemedicine Ltd. to 15.18%.
• The increase in ownership stems from the full subscription by the Reporting Persons in a rights offering completed by SHL Telemedicine Ltd. on December 3, 2025.
• The Reporting Persons collectively invested approximately $3.2 million in the rights offering, acquiring additional ordinary shares at approximately $0.76 per share.
• Following the rights offering, the Reporting Persons beneficially own an aggregate of 5,624,944 ordinary shares of SHL Telemedicine Ltd., based on 37,059,946 ordinary shares outstanding as of December 3, 2025.
• Ido Nouberger directly invested approximately $0.8 million for 1,128,168 ordinary shares, and Victor Shamrich directly invested approximately $0.2 million for 216,000 ordinary shares.
• Value Base Ltd. directly invested approximately $1.3 million for 1,708,077 ordinary shares, and Harmony Base, Limited Partnership invested approximately $0.9 million for 1,166,463 ordinary shares.

Sentiment

Score: 7

Explanation: A significant shareholder group increased its stake and invested substantial capital in the company's rights offering, indicating confidence in the issuer.

Positives

• A significant shareholder group, Value Base Ltd. and its affiliates, has demonstrated strong confidence in SHL Telemedicine Ltd. by fully participating in a rights offering and increasing their stake.
• The investment of approximately $3.2 million by the Reporting Persons provides additional capital to SHL Telemedicine Ltd.

Future Outlook

This filing primarily details a change in beneficial ownership and capital investment by a significant shareholder group. It does not contain explicit forward-looking statements or guidance from SHL Telemedicine Ltd. regarding its future operations or financial performance.

Management Comments

• Ido Nouberger signed on behalf of Value Base Ltd. as CEO, Value Base Hedge Fund Ltd. as Director, and in his individual capacity.
• Victor Shamrich signed on behalf of Value Base Ltd. as Chairman, Value Base Hedge Fund Ltd. as Director, and in his individual capacity.

Industry Context

This announcement reflects a specific capital raise and ownership change for SHL Telemedicine Ltd. and does not provide broader insights into industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The company received additional capital from the rights offering, and a major shareholder group increased its commitment, potentially signaling stability and confidence.
• Company: SHL Telemedicine Ltd. successfully raised capital through the rights offering.

Key Dates

Recommendation

The filing indicates a significant shareholder group, Value Base Ltd. and its affiliates, has increased its stake in SHL Telemedicine Ltd. to 15.18% by fully participating in a rights offering, investing approximately $3.2 million. This demonstrates strong confidence from a major investor, which is generally a positive signal. However, without additional financial performance data or strategic updates from SHL, a 'hold' recommendation is appropriate, acknowledging the positive insider action while awaiting broader company performance indicators.

Keywords

SHL Telemedicine, Value Base, Schedule 13D, Rights Offering, Beneficial Ownership, Shareholder, Investment, Equity